PEYTON BROUWER: Open Payments
NPI 1164165353 · ROSWELL, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,420 in 97 payments from 19 companies in 2025. Trend: 2023 $4,251 · 2024 $3,224 · 2025 $2,420
Food & beverage: $2,420
| Company | Payments | Amount |
|---|---|---|
| Arcutis Biotherapeutics, Inc. | 19 | $429 |
| Galderma Laboratories, L.P. | 7 | $360 |
| ABBVIE INC. | 13 | $320 |
| Organon LLC | 8 | $259 |
| UCB, Inc. | 10 | $165 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 15 | $146 |
| Amgen Inc. | 3 | $126 |
| Janssen Scientific Affairs, LLC | 1 | $123 |
| GENZYME CORPORATION | 3 | $113 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $80 |
Products named: Zoryve, NEMLUVIO, VTAMA, TREMFYA, Bimzelx, RINVOQ, DUPIXENT, JUBLIA.
Industry payments across GA — which companies pay providers there.
